KR970005302B1 - 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제 - Google Patents

이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제 Download PDF

Info

Publication number
KR970005302B1
KR970005302B1 KR1019930702352A KR930702352A KR970005302B1 KR 970005302 B1 KR970005302 B1 KR 970005302B1 KR 1019930702352 A KR1019930702352 A KR 1019930702352A KR 930702352 A KR930702352 A KR 930702352A KR 970005302 B1 KR970005302 B1 KR 970005302B1
Authority
KR
South Korea
Prior art keywords
pyrid
compound
piperidine
benzo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930702352A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 알커
로버트 존 바스
켈빈 쿠퍼
Original Assignee
화이자 인크.
데이비드 존 우드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인크., 데이비드 존 우드 filed Critical 화이자 인크.
Application granted granted Critical
Publication of KR970005302B1 publication Critical patent/KR970005302B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Prostheses (AREA)
KR1019930702352A 1991-02-13 1992-01-24 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제 Expired - Fee Related KR970005302B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9102997.5 1991-02-13
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents
PCT/EP1992/000163 WO1992014734A1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h1 antagonists

Publications (1)

Publication Number Publication Date
KR970005302B1 true KR970005302B1 (ko) 1997-04-15

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930702352A Expired - Fee Related KR970005302B1 (ko) 1991-02-13 1992-01-24 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
JPH11510180A (ja) * 1995-08-05 1999-09-07 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド イミダゾピリジン誘導体
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
DK1311269T3 (da) 2000-08-04 2012-03-26 Dmi Biosciences Inc Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
AU2008349239B2 (en) 2008-01-30 2012-12-06 Nippon Zoki Pharmaceutical Co., Ltd. Piperidine derivative
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US9296731B2 (en) * 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
BR112014007675A2 (pt) 2011-10-10 2017-04-18 Ampio Pharmaceuticals Inc tratamento de doença articular degenerativa
BR112014007657A2 (pt) 2011-10-10 2017-04-11 Ampio Pharmaceuticals Inc dispositivos médicos implantáveis com tolerância imune aperfeiçoada e métodos para produção e implantação
WO2013063413A1 (en) * 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
HK1246669A1 (zh) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. 人血清白蛋白低分子量组分在疾病治疗中的应用
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
WO1989008653A1 (en) * 1988-03-15 1989-09-21 G.D. Searle & Co. 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
DE68926976T2 (de) * 1988-04-28 1997-02-27 Schering Corp Kondensierte polyzyklische Verbindungen, Zusammenstellungen, Verfahren zur Herstellung und deren Anwendung als PAF-antagonistische, antihistaminische und/oder anti-inflammatorische Agenzien
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
RO109450B1 (ro) * 1990-05-09 1995-02-28 Pfizer Derivati de imidazo (4,5-c) piridine, procedee de obtinere, compozitii care ii contin si metoda de tratament

Also Published As

Publication number Publication date
RU2114845C1 (ru) 1998-07-10
EP0572425B1 (en) 1994-08-03
GB9102997D0 (en) 1991-03-27
MX9200589A (es) 1992-10-01
FI933531A0 (fi) 1993-08-10
NO932889D0 (no) 1993-08-13
CN1040326C (zh) 1998-10-21
AU650322B2 (en) 1994-06-16
NO300592B1 (no) 1997-06-23
AU1168392A (en) 1992-09-15
BR9205615A (pt) 1994-05-17
DE69200304D1 (de) 1994-09-08
US5358953A (en) 1994-10-25
CZ280504B6 (cs) 1996-02-14
YU48238B (sh) 1997-08-22
CN1064275A (zh) 1992-09-09
JP2506541B2 (ja) 1996-06-12
FI933531L (fi) 1993-08-10
IL100887A0 (en) 1992-11-15
DK0572425T3 (da) 1994-09-12
HU211202A9 (en) 1995-11-28
PL169304B1 (pl) 1996-06-28
HU9302327D0 (en) 1993-10-28
EP0572425A1 (en) 1993-12-08
JPH06504992A (ja) 1994-06-09
ZA921005B (en) 1993-08-12
MY108437A (en) 1996-09-30
ATE109482T1 (de) 1994-08-15
IE920449A1 (en) 1992-08-12
DE69200304T2 (de) 1994-12-08
ES2059212T3 (es) 1994-11-01
NZ241597A (en) 1993-04-28
NO932889L (no) 1993-08-13
FI933531A7 (fi) 1993-08-10
CA2099381A1 (en) 1992-08-14
HUT65947A (en) 1994-08-29
IL100887A (en) 1996-01-19
WO1992014734A1 (en) 1992-09-03
YU14392A (sh) 1994-11-15
TW227000B (enExample) 1994-07-21
IE65125B1 (en) 1995-10-04
CS42592A3 (en) 1992-09-16
CA2099381C (en) 1996-07-09
EG20085A (en) 1997-05-31

Similar Documents

Publication Publication Date Title
KR970005302B1 (ko) 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제
US6642224B1 (en) Diazepan derivatives or salts thereof
JPH089596B2 (ja) ジアリールメチルピペリジンまたはピペラジンのピリジンおよびピリジンｎ−オキシド誘導体、並びにそれらの組成物および使用方法
JPWO1999020620A1 (ja) イソキノリン誘導体及び医薬
US5250531A (en) Dihydropyrimidine antiallergy agents
JPH0673038A (ja) ビフェニル誘導体、これらの化合物を含む医薬組成物及びそれらの調製法
JP2003527426A (ja) トロンビン阻害薬
CZ302792A3 (en) Intima atherosclerotic concretion inhibitor
JP2002508780A (ja) 新規な化合物
FI93013B (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi
PT93603A (pt) Processo para a preparacao de agentes anti-alergicos de di-hidropirina
JPS63139167A (ja) ジヒドロピリジン抗アレルギー及び抗炎症剤
PT87604B (pt) Processo para a preparacao de agentes anti-alergicos e anti-inflamatorios di-hidropiridinicos
JPH02129175A (ja) ベンゾオキサゾリノン誘導体
KR920003116B1 (ko) 2,3-디히드로-1h-인덴 유도체의 제조방법
JPH07502007A (ja) 治療用のベンズアザピン化合物
US4929616A (en) Novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxides, a process for the preparation thereof, and pharmaceutical preparations containing these compounds
GB2171997A (en) 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives
US5714501A (en) Piperidine derivatives
JP2000516206A (ja) 新規な化合物
JPH11302174A (ja) 細胞接着阻害剤
JPH064637B2 (ja) 新規なインドール誘導体
US4851411A (en) 5-monoaryl as.-triazin-3-ones substituted in 2-position, and their use as medicaments
JPH05507932A (ja) イミダゾピリジンｐａｆ拮抗薬
SU1438611A3 (ru) Способ получени производных 1,5-бензоксатиепина или его кислотно-аддитивных солей

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20000723

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20000723

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000